<?xml version="1.0" encoding="UTF-8"?>
<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema"
              xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema"
              xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema"
              xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
              xmlns:dct="http://purl.org/dc/terms/"
              xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
              xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/"
              xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/"
              xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/"
              xmlns:cja="http://www.elsevier.com/xml/cja/schema"
              xmlns:ja="http://www.elsevier.com/xml/ja/schema"
              xmlns:bk="http://www.elsevier.com/xml/bk/schema"
              xmlns:ce="http://www.elsevier.com/xml/common/schema"
              xmlns:mml="http://www.w3.org/1998/Math/MathML"
              xmlns:cals="http://www.elsevier.com/xml/common/cals/schema"
              xmlns:tb="http://www.elsevier.com/xml/common/table/schema"
              xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema"
              xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema"
              xmlns:xlink="http://www.w3.org/1999/xlink">
   <rdf:RDF>
      <rdf:Description rdf:about="http://dx.doi.org/10.1016/j.jtcms.2022.01.002">
         <dct:format>application/xml</dct:format>
         <dct:title>Mechanism of mitochondrial protection by the Buyin Qianzheng formula in a Parkin overexpression cell model</dct:title>
         <dct:creator>Cuicui Cheng</dct:creator>
         <dct:creator>Yushan Gao</dct:creator>
         <dct:creator>Cong Gai</dct:creator>
         <dct:creator>Wandi Feng</dct:creator>
         <dct:creator>Haojie Ma</dct:creator>
         <dct:creator>Jing Feng</dct:creator>
         <dct:creator>Zhenyu Guo</dct:creator>
         <dct:creator>Shujing Zhang</dct:creator>
         <dct:creator>Jie Wu</dct:creator>
         <dct:creator>Hongmei Sun</dct:creator>
         <dct:subject>
            <rdf:Bag>
               <rdf:li>Parkinson's disease</rdf:li>
               <rdf:li>Parkin overexpression</rdf:li>
               <rdf:li>Mitochondria</rdf:li>
               <rdf:li>Buyin Qianzheng formula</rdf:li>
               <rdf:li>Neurotoxin 1-methyl-4-phenylpyridinium ion</rdf:li>
               <rdf:li>SH-SY5Y</rdf:li>
               <rdf:li>Mitofusin 2</rdf:li>
               <rdf:li>Dynamic-related protein 1</rdf:li>
            </rdf:Bag>
         </dct:subject>
         <dct:description>Journal of Traditional Chinese Medical Sciences 9 (2022) 59-68. doi:10.1016/j.jtcms.2022.01.002</dct:description>
         <prism:aggregationType>journal</prism:aggregationType>
         <prism:publicationName>Journal of Traditional Chinese Medical Sciences</prism:publicationName>
         <prism:copyright>© 2022 Beijing University of Chinese Medicine. Production and hosting by Elsevier B.V.</prism:copyright>
         <dct:publisher>Elsevier B.V.</dct:publisher>
         <prism:issn>2095-7548</prism:issn>
         <prism:volume>9</prism:volume>
         <prism:number>1</prism:number>
         <prism:coverDisplayDate>January 2022</prism:coverDisplayDate>
         <prism:pageRange>59-68</prism:pageRange>
         <prism:startingPage>59</prism:startingPage>
         <prism:endingPage>68</prism:endingPage>
         <prism:doi>10.1016/j.jtcms.2022.01.002</prism:doi>
         <prism:url>http://dx.doi.org/10.1016/j.jtcms.2022.01.002</prism:url>
         <dct:identifier>doi:10.1016/j.jtcms.2022.01.002</dct:identifier>
         <oa:openAccessInformation>
            <oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus>
            <oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2022-01-02T00:48:07Z</oa:openAccessEffective>
            <oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
               <oa:sponsorName>Beijing University of Chinese Medicine</oa:sponsorName>
               <oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#FundingBody</oa:sponsorType>
            </oa:sponsor>
            <oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense>
         </oa:openAccessInformation>
         <cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY-NC-ND license.</cp:licenseLine>
      </rdf:Description>
   </rdf:RDF>
   <dp:document-properties>
      <dp:aggregation-type>Journals</dp:aggregation-type>
      <dp:version-number>S300.1</dp:version-number>
   </dp:document-properties>
   <ja:article docsubtype="fla" version="5.6" xml:lang="en">
      <ja:item-info>
         <ja:jid>JTCMS</ja:jid>
         <ja:aid>358</ja:aid>
         <ce:pii>S2095-7548(22)00001-1</ce:pii>
         <ce:doi>10.1016/j.jtcms.2022.01.002</ce:doi>
         <ce:copyright type="society" year="2022">Beijing University of Chinese Medicine</ce:copyright>
      </ja:item-info>
      <ja:head>
         <ce:article-footnote>
            <ce:note-para id="ntpara0010" view="all">Peer review under responsibility of Beijing University of Chinese Medicine.</ce:note-para>
         </ce:article-footnote>
         <ce:title id="title0010">Mechanism of mitochondrial protection by the Buyin Qianzheng formula in a Parkin overexpression cell model</ce:title>
         <ce:author-group id="augrp0010">
            <ce:author id="au1" author-id="S2095754822000011-ed4a1a62e63bba7626c0b0cad85532af">
               <ce:given-name>Cuicui</ce:given-name>
               <ce:surname>Cheng</ce:surname>
               <ce:cross-ref refid="aff1">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="fn1">
                  <ce:sup loc="post">1</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au2" author-id="S2095754822000011-1f553098723927e5c14964cd1a61e2ca">
               <ce:given-name>Yushan</ce:given-name>
               <ce:surname>Gao</ce:surname>
               <ce:cross-ref refid="aff1">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="fn1">
                  <ce:sup loc="post">1</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au3" author-id="S2095754822000011-b2d4281d4211f14d6211b0ec57bd4149">
               <ce:given-name>Cong</ce:given-name>
               <ce:surname>Gai</ce:surname>
               <ce:cross-ref refid="aff1">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au4" author-id="S2095754822000011-0d945dd32d02296726eb8a1008af26ee">
               <ce:given-name>Wandi</ce:given-name>
               <ce:surname>Feng</ce:surname>
               <ce:cross-ref refid="aff1">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au5" author-id="S2095754822000011-1a04fdc46d5ce5e45ac387461c800855">
               <ce:given-name>Haojie</ce:given-name>
               <ce:surname>Ma</ce:surname>
               <ce:cross-ref refid="aff2">
                  <ce:sup loc="post">b</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au6" author-id="S2095754822000011-ca0acdf674cefc9f82d324bca78f71bf">
               <ce:given-name>Jing</ce:given-name>
               <ce:surname>Feng</ce:surname>
               <ce:cross-ref refid="aff1">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au7" author-id="S2095754822000011-662f11f84df9e6e38c1c87c282d90747">
               <ce:given-name>Zhenyu</ce:given-name>
               <ce:surname>Guo</ce:surname>
               <ce:cross-ref refid="aff1">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au8" author-id="S2095754822000011-2519a684ba2ea2df6f5cd2e7d21f97b1">
               <ce:given-name>Shujing</ce:given-name>
               <ce:surname>Zhang</ce:surname>
               <ce:cross-ref refid="aff1">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au9" author-id="S2095754822000011-cc6ec33dc7a572af47aced8dc5fcb33d">
               <ce:given-name>Jie</ce:given-name>
               <ce:surname>Wu</ce:surname>
               <ce:cross-ref refid="aff3">
                  <ce:sup loc="post">c</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au10"
                       author-id="S2095754822000011-54efef42faf290f1a86fc24f0032d6d4">
               <ce:given-name>Hongmei</ce:given-name>
               <ce:surname>Sun</ce:surname>
               <ce:cross-ref refid="aff1">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="cor1">
                  <ce:sup loc="post">∗</ce:sup>
               </ce:cross-ref>
               <ce:e-address type="email" xlink:href="mailto:hongmei_sun@yeah.net" id="eadd0010">hongmei_sun@yeah.net</ce:e-address>
            </ce:author>
            <ce:affiliation id="aff1"
                            affiliation-id="S2095754822000011-29f50aacc4c7baeccc720469ddc001e2">
               <ce:label>a</ce:label>
               <ce:textfn>School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China</ce:textfn>
               <sa:affiliation>
                  <sa:organization>School of Traditional Chinese Medicine</sa:organization>
                  <sa:organization>Beijing University of Chinese Medicine</sa:organization>
                  <sa:city>Beijing</sa:city>
                  <sa:postal-code>102488</sa:postal-code>
                  <sa:country>China</sa:country>
               </sa:affiliation>
               <ce:source-text id="srct0010">School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, China</ce:source-text>
            </ce:affiliation>
            <ce:affiliation id="aff2"
                            affiliation-id="S2095754822000011-2b982ef75a782610255bf1d16c6b0265">
               <ce:label>b</ce:label>
               <ce:textfn>Institute of Health Sciences, National Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Institute of Health Sciences</sa:organization>
                  <sa:organization>National Engineering Research Center for Beijing Biochip Technology</sa:organization>
                  <sa:city>Beijing</sa:city>
                  <sa:postal-code>102206</sa:postal-code>
                  <sa:country>China</sa:country>
               </sa:affiliation>
               <ce:source-text id="srct0015">Institute of Health Sciences, National Engineering Research Center for Beijing Biochip Technology, Beijing 102206, China</ce:source-text>
            </ce:affiliation>
            <ce:affiliation id="aff3"
                            affiliation-id="S2095754822000011-00e2447fac93e94a67842e48a4261100">
               <ce:label>c</ce:label>
               <ce:textfn>Department of Physiology, Mayo Clinic Hospital, Phoenix, 85054, USA</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Department of Physiology</sa:organization>
                  <sa:organization>Mayo Clinic Hospital</sa:organization>
                  <sa:city>Phoenix</sa:city>
                  <sa:postal-code>85054</sa:postal-code>
                  <sa:country>USA</sa:country>
               </sa:affiliation>
               <ce:source-text id="srct0020">Department of Physiology, Mayo Clinic Hospital, Phoenix, 85054, USA</ce:source-text>
            </ce:affiliation>
            <ce:correspondence id="cor1">
               <ce:label>∗</ce:label>
               <ce:text>Corresponding author.</ce:text>
            </ce:correspondence>
            <ce:footnote id="fn1">
               <ce:label>1</ce:label>
               <ce:note-para id="ntpara0015" view="all">These authors have contributed equally to this work.</ce:note-para>
            </ce:footnote>
         </ce:author-group>
         <ce:date-received day="10" month="11" year="2021"/>
         <ce:date-revised day="31" month="12" year="2021"/>
         <ce:date-accepted day="1" month="1" year="2022"/>
         <ce:abstract xml:lang="en" id="abs0010" view="all" class="author">
            <ce:section-title id="sectitle0010">Abstract</ce:section-title>
            <ce:abstract-sec id="abssec0010" view="all">
               <ce:section-title id="sectitle0015">Objective</ce:section-title>
               <ce:simple-para id="abspara0010" view="all">To identify the molecular mechanisms of the effects of the Buyin Qianzheng formula (BYQZF) on the mitochondrial dynamics in a Parkin overexpression Parkinson's disease (PD) cell model.</ce:simple-para>
            </ce:abstract-sec>
            <ce:abstract-sec id="abssec0015" view="all">
               <ce:section-title id="sectitle0020">Methods</ce:section-title>
               <ce:simple-para id="abspara0015" view="all">First, a stable Parkin overexpression cell model was constructed using plasmid transfection. Then, we examined the protective effect of BYQZF on the mitochondrial dysfunction of the Parkin overexpression PD cell model induced by neurotoxin 1-methyl-4-phenylpyridinium ion (MPP<ce:sup loc="post">+</ce:sup>). The mRNA expression level of Parkin was evaluated using real-time quantitative PCR. The cell survival rate was detected using the Cell Counting Kit-8 assay. We evaluated the cellular adenosine triphosphate (ATP) levels using luciferase assays. A laser scanning confocal microscope was used to observe the mitochondrial morphology, activity, and mitochondrial membrane potential (ΔΨm). Western blot was conducted to evaluate the levels of the fusion proteins mitofusin1, mitofusin2, optic atrophy 1, dynamin-related protein 1, and mitochondrial fission protein 1.</ce:simple-para>
            </ce:abstract-sec>
            <ce:abstract-sec role="results" id="abssec0020" view="all">
               <ce:section-title id="sectitle0025">Results</ce:section-title>
               <ce:simple-para id="abspara0020" view="all">Parkin overexpression attenuated MPP<ce:sup loc="post">+</ce:sup> -induced mitochondrial damage, increased mitochondrial activity and ΔΨm. BYQZF increased the survival of MPP<ce:sup loc="post">+</ce:sup>-induced cells that overexpressed Parkin and upregulated the mitochondrial form factor and activity. It also inhibited a decrease in the ΔΨm and ATP levels. These findings suggested that BYQZF protected against MPP<ce:sup loc="post">+</ce:sup>-induced mitochondrial dysfunction and enhanced the protective effect of Parkin overexpression. Furthermore, the formula upregulated the expression of the fusion proteins mitofusin1, mitofusin2, and optic atrophy 1 (closely related to mitochondrial quality remodeling), and reduced the expression of the fission protein dynamic-related protein 1, as well as mitochondrial fission protein 1.</ce:simple-para>
            </ce:abstract-sec>
            <ce:abstract-sec role="conclusion" id="abssec0025" view="all">
               <ce:section-title id="sectitle0030">Conclusion</ce:section-title>
               <ce:simple-para id="abspara0025" view="all">The mechanism by which BYQZF increased the mitochondrial protective effect of Parkin gene overexpression in MPP<ce:sup loc="post">+</ce:sup> -induced cells may be related to improving mitochondrial function and regulating the balance of mitochondrial division and fusion proteins.</ce:simple-para>
            </ce:abstract-sec>
         </ce:abstract>
         <ce:keywords xml:lang="en" id="kwrds0010" view="all" class="keyword">
            <ce:section-title id="sectitle0035">Keywords</ce:section-title>
            <ce:keyword id="kwrd0010">
               <ce:text>Parkinson's disease</ce:text>
            </ce:keyword>
            <ce:keyword id="kwrd0015">
               <ce:text>Parkin overexpression</ce:text>
            </ce:keyword>
            <ce:keyword id="kwrd0020">
               <ce:text>Mitochondria</ce:text>
            </ce:keyword>
            <ce:keyword id="kwrd0025">
               <ce:text>Buyin Qianzheng formula</ce:text>
            </ce:keyword>
            <ce:keyword id="kwrd0030">
               <ce:text>Neurotoxin 1-methyl-4-phenylpyridinium ion</ce:text>
            </ce:keyword>
            <ce:keyword id="kwrd0035">
               <ce:text>SH-SY5Y</ce:text>
            </ce:keyword>
            <ce:keyword id="kwrd0040">
               <ce:text>Mitofusin 2</ce:text>
            </ce:keyword>
            <ce:keyword id="kwrd0045">
               <ce:text>Dynamic-related protein 1</ce:text>
            </ce:keyword>
         </ce:keywords>
      </ja:head>
   </ja:article>
</doc:document>
